pharmaceuticals

Public Citizen Petition Seeks Generic GLP-1 Drugs to Lower Obesity & Diabetes Costs

by

The Battle for Affordable GLP-1s: A Turning Point for US Healthcare? The rising cost of prescription drugs continues to dominate healthcare headlines, and a recent petition filed by Public Citizen with the Department of Health and Human Services (HHS) highlights a particularly contentious area: GLP-1 receptor agonists. These medications, like semaglutide (Ozempic, Wegovy) and tirzepatide, … Read more

Merck Urged to Plan Global Access for Promising Monthly HIV Prevention Pill

by

The Future of HIV Prevention: A Monthly Pill on the Horizon? Patient advocacy groups are already mobilizing, urging pharmaceutical company Merck to ensure global access to a potentially groundbreaking HIV prevention pill, MK-8527. This isn’t just another drug in development; it represents a significant shift in how we approach PrEP (pre-exposure prophylaxis), moving away from … Read more

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

by

Future Trends Shaping the Hypochlorous Acid (HOCl) Market Why HOCl Is Gaining Momentum in Healthcare Stabilized hypochlorous acid (HOCl) has emerged as a versatile, non‑toxic solution for wound care, dermatology, eye care, and even disinfection. Its ability to reduce itch, pain, and scarring without harming healthy tissue makes it a preferred alternative to traditional antiseptics. … Read more

Oregon Primate Center May Become Sanctuary After NIH Vote | STAT News

by

Oregon Primate Center Faces Potential Shift to Sanctuary: A Sign of Changing Times in Biomedical Research The Oregon Health & Science University (OHSU) board of directors has authorized negotiations with the National Institutes of Health (NIH) that could dramatically reshape the future of the Oregon National Primate Research Center (ONPRC). The potential outcome? A transition … Read more

FDA Warns Hims & Hers Pharmacy Over Wegovy Compounding Incident

by

FDA Scrutiny Intensifies Compounded Drug Landscape: What’s Next for Wegovy and Beyond? The U.S. Food and Drug Administration is increasing its oversight of compounded drugs, particularly those mimicking popular medications like Novo Nordisk’s Wegovy. A recent warning letter issued to MedisourceRx, a compounding pharmacy owned by Hims & Hers, highlights growing concerns about patient safety … Read more

Aerska Therapeutics Secures $39 Million to Advance Iron‑Based Brain‑Targeted Gene Silencing Platform

by

The Future of Brain-Targeted RNA Therapies: A Recent Era in Neurological Disease Treatment Aerska Therapeutics, a Dublin and London-based biotech startup, is pioneering a novel approach to treating neurological diseases by delivering RNA interference (RNAi) therapies directly to the brain. Recent financing rounds, totaling $39 million, highlight growing investor confidence in this innovative technology. This … Read more

Novo Nordisk stock rises; Hims & Hers pulls copycat weight-loss pill

by

Hims & Hers Retreats from Wegovy Copycat: What It Means for the Future of Weight-Loss Drugs Novo Nordisk shares surged Monday after Hims & Hers announced it would discontinue sales of its cheaper, compounded version of the weight-loss pill Wegovy. The move comes after threats of legal action from Novo Nordisk and scrutiny from the … Read more

TrumpRx: Are the Drug Prices Really the Lowest?

by

TrumpRx: A Discount Drug Platform or Just a Clever Illusion? WASHINGTON — President Trump’s recently launched TrumpRx website promises the “lowest prices anywhere in the world” for prescription drugs. Though, a closer look reveals a more complex picture. Whereas the platform offers discounts on 43 brand-name drugs, a significant portion – at least 22 – … Read more

Why pressure from Trump probably won’t push up drug prices in France

by

The Global Drug Price War: Trump, Macron, and the Future of Pharma The recent clash between US President Donald Trump and French President Emmanuel Macron over drug prices isn’t simply a transatlantic spat. It’s a symptom of a much larger, evolving struggle over the cost of pharmaceuticals and the future of the global pharmaceutical industry. … Read more

Hims & Hers Pauses Compounded Wegovy Sales After FDA Probe

by

The Rise and Fall of Hims & Hers’ Wegovy Copycat: A Sign of Things to Come? This week, Hims & Hers abruptly halted sales of its compounded version of Novo Nordisk’s weight-loss drug, Wegovy, following intense scrutiny from the FDA and the Department of Justice. The move underscores a growing tension in the telehealth and … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]